-
Aarey Drugs Analyst Review 2027: A Stock That Doubled on a Business Earning ₹1.37 Crore a Quarter
- November 17, 2026
- Posted by: Kunal Singla
- Category: Market
No Comments
Aarey Drugs & Pharmaceuticals has more than doubled from its 52-week low, yet it earned just ₹1.37 crore in Q2 FY27 and has no brokerage coverage. We look at the numbers behind the rally, margins, valuation and risks for 2027.